Applied Genetic Technologies - 48 Year Dividend History | AGTC

Historical dividend payout and yield for Applied Genetic Technologies (AGTC) since 1971. The current TTM dividend payout for Applied Genetic Technologies (AGTC) as of April 23, 2019 is $0.00. The current dividend yield for Applied Genetic Technologies as of April 23, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.081B $0.024B
Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.629B 12.24
Gilead Sciences (GILD) United States $78.878B 10.04
Bio-Techne Corp (TECH) United States $7.219B 48.64